Literature DB >> 11141487

Leukocyte-mediated endothelial cell injury and death in the diabetic retina.

A M Joussen1, T Murata, A Tsujikawa, B Kirchhof, S E Bursell, A P Adamis.   

Abstract

Endothelial cell death is a hallmark of diabetic retinopathy. Its occurrence is required for the formation of acellular (devitalized) capillaries, lesions that produce irreversible retinal ischemia through their inability to support blood flow. The mechanisms underlying diabetic retinal endothelial cell injury and death remain largely unknown. The current study demonstrates that adherent leukocytes are temporally and spatially associated with retinal endothelial cell injury and death within 1 week of streptozotocin-induced experimental diabetes in rats. Moreover, the antibody-based neutralization of intercellular adhesion molecule-1 and CD18 is shown to prevent both leukocyte adhesion and retinal endothelial cell injury and death. These data highlight the central and causal role of adherent leukocytes in the pathogenesis of diabetic retinopathy. They also underscore the potential utility of anti-intercellular adhesion molecule1- and anti-CD18-based therapies in the treatment of diabetic retinopathy, a newly recognized inflammatory disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11141487      PMCID: PMC1850259          DOI: 10.1016/S0002-9440(10)63952-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  14 in total

1.  Aldose reductase inhibition. The chemical key to the control of diabetic retinopathy?

Authors:  R N Frank
Journal:  Arch Ophthalmol       Date:  1990-09

2.  Neutrophil-mediated damage to vascular endothelium in the spontaneously hypertensive rat.

Authors:  W Ofosu-Appiah; G Sfeir; D Smith; T Richard
Journal:  Clin Immunol Immunopathol       Date:  1997-06

3.  Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy.

Authors:  S Schröder; W Palinski; G W Schmid-Schönbein
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

4.  Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes.

Authors:  F C Barouch; K Miyamoto; J R Allport; K Fujita; S E Bursell; L P Aiello; F W Luscinskas; A P Adamis
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-04       Impact factor: 4.799

5.  Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

Authors:  L P Aiello; E A Pierce; E D Foley; H Takagi; H Chen; L Riddle; N Ferrara; G L King; L E Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

6.  Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid.

Authors:  D S McLeod; D J Lefer; C Merges; G A Lutty
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

7.  A morphologic and autoradiographic study of cell death and regeneration in the retinal microvasculature of normal and diabetic rats.

Authors:  N K Sharma; T A Gardiner; D B Archer
Journal:  Am J Ophthalmol       Date:  1985-07-15       Impact factor: 5.258

8.  Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.

Authors:  H P Hammes; S Martin; K Federlin; K Geisen; M Brownlee
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

9.  Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate.

Authors:  A P Adamis; D T Shima; M J Tolentino; E S Gragoudas; N Ferrara; J Folkman; P A D'Amore; J W Miller
Journal:  Arch Ophthalmol       Date:  1996-01

10.  A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen.

Authors:  M S Diamond; T A Springer
Journal:  J Cell Biol       Date:  1993-01       Impact factor: 10.539

View more
  214 in total

1.  Is diabetic retinopathy an inflammatory disease?

Authors:  A P Adamis
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

2.  miR-15a/16 inhibits TGF-beta3/VEGF signaling and increases retinal endothelial cell barrier proteins.

Authors:  Eun-Ah Ye; Li Liu; Jena J Steinle
Journal:  Vision Res       Date:  2017-08-07       Impact factor: 1.886

Review 3.  Inflammation in diabetic retinopathy.

Authors:  Johnny Tang; Timothy S Kern
Journal:  Prog Retin Eye Res       Date:  2011-05-25       Impact factor: 21.198

4.  Parstatin suppresses ocular neovascularization and inflammation.

Authors:  Hu Huang; Panagiotis Vasilakis; Xiufeng Zhong; Ji-Kui Shen; Katerina Geronatsiou; Helen Papadaki; Michael E Maragoudakis; Sotirios P Gartaganis; Stanley A Vinores; Nikos E Tsopanoglou
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-10       Impact factor: 4.799

5.  The pathogenesis of diabetic retinopathy.

Authors:  M R Stanford
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

6.  Pharmacokinetics and safety of intravitreally delivered etanercept.

Authors:  Sascha Fauser; Hubert Kalbacher; Nils Alteheld; Kan Koizumi; Tim U Krohne; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-03-17       Impact factor: 3.117

7.  Attenuation of streptozotocin-induced microvascular changes in the mouse retina with the endothelin receptor A antagonist atrasentan.

Authors:  Zhongli Wang; Amit Singh Yadav; Wendy Leskova; Norman R Harris
Journal:  Exp Eye Res       Date:  2010-08-19       Impact factor: 3.467

8.  Beneficial effects of fenofibric acid on overexpression of extracellular matrix components, COX-2, and impairment of endothelial permeability associated with diabetic retinopathy.

Authors:  Sumon Roy; Dongjoon Kim; Cristina Hernández; Rafael Simó; Sayon Roy
Journal:  Exp Eye Res       Date:  2015-08-18       Impact factor: 3.467

9.  Caveolin-1 increases proinflammatory chemoattractants and blood-retinal barrier breakdown but decreases leukocyte recruitment in inflammation.

Authors:  Xiaoman Li; Xiaowu Gu; Timothy M Boyce; Min Zheng; Alaina M Reagan; Hui Qi; Nawajes Mandal; Alex W Cohen; Michelle C Callegan; Daniel J J Carr; Michael H Elliott
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-26       Impact factor: 4.799

10.  Angiogenic and Immunologic Proteins Identified by Deep Proteomic Profiling of Human Retinal and Choroidal Vascular Endothelial Cells: Potential Targets for New Biologic Drugs.

Authors:  Justine R Smith; Larry L David; Binoy Appukuttan; Phillip A Wilmarth
Journal:  Am J Ophthalmol       Date:  2018-03-17       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.